A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients

• Status: Completed
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Exploratory, international, multi-centre, randomized, investigator blinded study in acne

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Galderma R&D

Criteria

Inclusion Criteria:

• Male or female subjects aged 18 to 35 years inclusive

• Subjects with active, moderate acne

Exclusion Criteria:

• The subject has a secondary acne form (chloracne, drug-induced acne, etc.) (Screening)

• The subject has a severity of acne that is not amenable to treatment with CD0271-CD1579 (Screening)